The impact of ocular surface disease in glaucoma treatment
This article considers the impact of ocular surface disease on patients with glaucoma and the implications it can have on quality of life and adherence to treatment
28 April 2018
To view this content, please log in.
Not a member or subscriber? Join AOP today for access to a whole range of benefits, or subscribe to OT for immediate access to our premium content.
Advertisement
OT CPD See all View all OT CPD
-
Sleep disorders in the eye and related systemic disease
- CPD points: 1
- Closes: 01 Jul 2024
-
Dry eye disease and its impact on everyday wellbeing
- CPD points: 1
- Closes: 01 Jul 2024
-
Repeated low-level red-light therapy: the future of myopia management?
- CPD points: 1
- Closes: 01 Jul 2024